Invention Grant
- Patent Title: Nitrogen-containing heterocyclic compound
-
Application No.: US15318552Application Date: 2015-06-11
-
Publication No.: US10214508B2Publication Date: 2019-02-26
- Inventor: Masaki Ogino , Eiji Kimura , Shinkichi Suzuki , Tomoko Ashizawa , Toshihiro Imaeda , Ikuo Fujimori , Ryosuke Arai
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2014-122919 20140613
- International Application: PCT/JP2015/066907 WO 20150611
- International Announcement: WO2015/190564 WO 20151217
- Main IPC: C07D401/10
- IPC: C07D401/10 ; C07D401/14 ; C07D405/14 ; A61K31/44 ; A61K31/4439 ; A61K31/444 ; C07D213/81 ; C07D405/12
Abstract:
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as a medicament such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the attached DESCRIPTION.
Public/Granted literature
- US20170121308A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Public/Granted day:2017-05-04
Information query
